Publications en collaboration avec des chercheurs de Universidad de Alcalá (43)

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  2. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism

    JAMA Cardiology, Vol. 9, Núm. 1, pp. 64-70

  3. Highlights 57th SEPAR Congress

    Open Respiratory Archives, Vol. 6, Núm. 4

  4. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

  5. Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses

    European Journal of Internal Medicine

  6. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  7. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

  8. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Identification of Low-risk Patients With Acute Symptomatic Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 575-580

  3. Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings

    Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 1, pp. 34-46

  4. The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism

    American Heart Journal, Vol. 257, pp. 62-68

2022

  1. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial

    Thrombosis Journal, Vol. 20, Núm. 1

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  5. Intermediate Respiratory Care Units (RICUs) During the COVID-19 Pandemic. The Reality

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 284-286

  6. Major bleeding in patients with pulmonary embolism presenting with syncope

    European journal of clinical investigation, Vol. 52, Núm. 7, pp. e13774

  7. The 7 Cardinal Sins of COPD in Spain

    Archivos de Bronconeumologia

  8. [Translated article] International consensus document on obstructive sleep apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. T52-T68